Saratov JOURNAL of Medical and Scientific Research

Effect of estrogen deficiency on the lipid profile in women in different age periods

Year: 2014, volume 10 Issue: №3 Pages: 396-400
Heading: Obstetrics and Gynecology Article type: Original article
Authors: Neyfeld I.V., Rogozhina I.E., Kirichuk V.F., Kiselev A.R., Zhirnyakov A.l., Bobyleva I.V.
Organization: Saratov Institute of Cardiology, Russia, Saratov State Medical University

The aim of the study is to evaluate influence of estrogen deficiency on lipid profile in women of different age. Material and Methods. 189 women with normal body weight: 44 women with premature menopause (aged <40 years), 69 women with early menopause (aged 40-45 years), and 76 women with natural menopause (aged 46-55 years) have been studied. In all women identification of clinical status has been performed during clinical examination. Results. It is shown that increasing age associated with increasing total cholesterol, triglycerides, low-density lipoprotein (LDL), very low density lipoproteins (VLDL) (p<0.05). We have not observed a significant association between age and level of high-density lipoprotein (HDL) (p=0.117). According with increased age, atherogenic index of plasma (AIP) increases from initial -0.17±0.09 (M±o) to 0.09±0.47 (p<0.05) in women with premature menopause, and to 0.14±0.21 (p<0.05) in other women. Final level of AIP was similar between women aged 40-45 years and women aged 46-55 years (p=0.084). Conclusion. Lipid metabolism disorders were assessed in 73.5% of women with estrogen deficiency. According to the age factor the rate of women with normal lipid metabolism decreases (x2=10,165, p=0.026).

1. de VilliersTJ, GassML, HainesCJ, etal. Global consensus statement on menopausal hormone therapy. Climacteric 2013; 16 (2): 203-204; 2. Kim ES, Menon V. Status of women in cardiovascular clinical trials. Arterioscler Thromb Vase Biol 2009; 29: 279-283; 3. Neufeld IW, Zhirnyakov Al, Skupova IN. Risk factors for cardiovascular disease in women. Bulletin of Medical Internet Conferences 2012; 2 (12): 994-996; 4. Smiley DA, Khalil RA. Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels. Curr Med Chem 2009; 16 (15): 1863-1887; 5. Smetnik WP. Medicine menopause. Yaroslavl: Litera, 2006; 848 p.; 6. Shuster LT, Rhodes DJ, Gostout BS, et al. Premature menopause or early menopause: Long-term health consequences. Maturitas2010; 65(2): 161-166; 7. Grady D, Herrington D, Bittner V, et al. HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288 (1): 49-57; 8. Harman SM, Vittinghoff E, Brinton EA, et al. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med 2011; 124 (3): 199-205; 9. Friedwald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502; 10. Dobiasova M. AlP-atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek 2006; 52 (1): 64-71; 11. Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall ЕЕ. Risk factors for coronary heart disease: implications of gender. Cardiovascular Research 2002; 53 (3): 538-549; 12. Okonofua ЕЕ, Lawal A, Bamgbose JK. Features of Menopause and Menopausal age in Nigerian women. Int J Gynaecol Obstet 1990; 31 (4): 341-345.

2014_03_396-400.pdf486.89 KB

No votes yet